• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

现行疫苗和抗体生产的 GMP 标准:概述。

Current GMP standards for the production of vaccines and antibodies: An overview.

机构信息

Millenium Institute on Immunology and Immunotherapy, Departamento de Genética Molecular y Microbiología, Facultad de Ciencias Biológicas, Pontificia Universidad Católica de Chile, Santiago, Chile.

Deeks Pharmaceutical Consulting Services, Rockville, MD, United States.

出版信息

Front Public Health. 2022 Nov 3;10:1021905. doi: 10.3389/fpubh.2022.1021905. eCollection 2022.

DOI:10.3389/fpubh.2022.1021905
PMID:36743162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9891391/
Abstract

The manufacture of pharmaceutical products made under good manufacturing practices (GMP) must comply with the guidelines of national regulatory bodies based on international or regional compendia. The existence of this type of regulation allows pharmaceutical laboratories to count on the standardization of high-quality production processes, obtaining a safe product for human use, with a positive impact on public health. In addition, the COVID-19 pandemic highlights the importance of having more and better-distributed manufacturing plants, emphasizing regions such as Latin America. This review shows the most important GMP standards in the world and, in particular, their relevance in the production of vaccines and antibodies.

摘要

药品的生产必须符合基于国际或地区典集的国家监管机构的指导原则,这些药品是按照良好生产规范(GMP)生产的。这种规定的存在使制药实验室能够依靠高质量生产过程的标准化,获得可安全用于人类的产品,从而对公共健康产生积极影响。此外,COVID-19 大流行凸显了拥有更多和分布更广的生产工厂的重要性,拉丁美洲等地区受到了特别关注。这篇综述展示了世界上最重要的 GMP 标准,特别是它们在疫苗和抗体生产中的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/9891391/e32b13c7f762/fpubh-10-1021905-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/9891391/546740263380/fpubh-10-1021905-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/9891391/e32b13c7f762/fpubh-10-1021905-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/9891391/546740263380/fpubh-10-1021905-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/9891391/e32b13c7f762/fpubh-10-1021905-g0002.jpg

相似文献

1
Current GMP standards for the production of vaccines and antibodies: An overview.现行疫苗和抗体生产的 GMP 标准:概述。
Front Public Health. 2022 Nov 3;10:1021905. doi: 10.3389/fpubh.2022.1021905. eCollection 2022.
2
Aid conditionalities, international Good Manufacturing Practice standards and local production rights: a case study of local production in Nepal.援助条件、国际药品生产质量管理规范标准与本土生产权:尼泊尔本土生产案例研究
Global Health. 2015 Jun 14;11:25. doi: 10.1186/s12992-015-0110-3.
3
The impact of COVID-19 and catch-up strategies on routine childhood vaccine coverage trends in Latin America: A systematic literature review and database analysis.COVID-19 疫情对拉丁美洲常规儿童疫苗接种覆盖率趋势的影响:系统文献回顾和数据库分析。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2102353. doi: 10.1080/21645515.2022.2102353. Epub 2022 Sep 9.
4
Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study.巴基斯坦当地制药行业实施和遵守国际公认质量标准的体制障碍和促进因素:一项定性研究。
Health Policy Plan. 2019 Jul 1;34(6):440-449. doi: 10.1093/heapol/czz054.
5
Evaluation of a Pilot: Inspection Facilitation and Collaboration Using a Mixed Reality Device.试点评估:使用混合现实设备进行检查促进和协作。
Ther Innov Regul Sci. 2024 Jan;58(1):11-15. doi: 10.1007/s43441-023-00594-2. Epub 2023 Nov 22.
6
Who Expert Committee on Biological Standardization.生物标准化专家委员会。
World Health Organ Tech Rep Ser. 2004;926:1-109.
7
WHO Expert Committee on Specifications for Pharmaceutical Preparations.世界卫生组织药物制剂规范专家委员会
World Health Organ Tech Rep Ser. 2011(961):1-428, back cover.
8
The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices.对比药品生产质量管理规范,生产高活性或致敏性药物的要求。
Acta Biomed. 2019 May 23;90(2):288-299. doi: 10.23750/abm.v90i2.8340.
9
Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.药品质量:巴西卫生监管局(ANVISA)在国际检查中发现的良好生产规范缺陷。
PLoS One. 2018 Aug 8;13(8):e0202084. doi: 10.1371/journal.pone.0202084. eCollection 2018.
10
Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.制药生产质量投资的成本效益:一家尼日利亚制药商的世卫组织药品生产质量管理规范认证前后情况
BMC Health Serv Res. 2017 Sep 18;17(1):665. doi: 10.1186/s12913-017-2610-8.

引用本文的文献

1
-Based Vaccine: A Promising Strategy for Type 1 Diabetes.基于疫苗:1型糖尿病的一种有前景的策略。
Vaccines (Basel). 2025 Apr 14;13(4):405. doi: 10.3390/vaccines13040405.
2
Insect-specific virus platforms for arbovirus vaccine development.用于虫媒病毒疫苗开发的昆虫特异性病毒平台。
Front Immunol. 2025 Mar 14;16:1521104. doi: 10.3389/fimmu.2025.1521104. eCollection 2025.
3
Serum-Free Suspension Culture of the C6/36 Cell Line for Chimeric Orthoflavivirus Vaccine Production.用于嵌合黄病毒疫苗生产的C6/36细胞系无血清悬浮培养

本文引用的文献

1
Increased Heme Oxygenase 1 Expression upon a Primary Exposure to the Respiratory Syncytial Virus and a Secondary Infection.初次暴露于呼吸道合胞病毒及再次感染时血红素加氧酶1表达增加。
Antioxidants (Basel). 2022 Jul 26;11(8):1453. doi: 10.3390/antiox11081453.
2
The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.卡介苗(BCG)和流感疫苗联合接种的安全性。
PLoS One. 2022 Jun 3;17(6):e0268042. doi: 10.1371/journal.pone.0268042. eCollection 2022.
3
BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and .
Viruses. 2025 Feb 12;17(2):250. doi: 10.3390/v17020250.
4
Good manufacturing practice inspections conducted by Tanzania medicines and medical devices authority: a comparative study of two fiscal years from 2018 to 2020.坦桑尼亚药品和医疗器械管理局进行的药品生产质量管理规范检查:2018年至2020年两个财政年度的比较研究
J Pharm Policy Pract. 2024 Sep 16;17(1):2399722. doi: 10.1080/20523211.2024.2399722. eCollection 2024.
5
Syphilis vaccine development: Aligning vaccine design with manufacturing requirements.梅毒疫苗研发:使疫苗设计与生产要求保持一致。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2399915. doi: 10.1080/21645515.2024.2399915. Epub 2024 Sep 11.
6
The Platform Technology Approach to mRNA Product Development and Regulation.mRNA产品开发与监管的平台技术方法。
Vaccines (Basel). 2024 May 11;12(5):528. doi: 10.3390/vaccines12050528.
7
Quality control in SARS-CoV-2 RBD-Fc vaccine production using LC-MS to confirm strain selection and detect contaminations from other strains.采用 LC-MS 进行 SARS-CoV-2 RBD-Fc 疫苗生产中的质量控制,以确认株选择并检测来自其他株的污染。
Sci Rep. 2024 Apr 26;14(1):9629. doi: 10.1038/s41598-024-59860-4.
8
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness.基于植物的新冠疫苗作为大流行防范措施出现的紧迫性。
Vaccines (Basel). 2023 Aug 9;11(8):1347. doi: 10.3390/vaccines11081347.
基于卡介苗的疫苗引发针对严重急性呼吸综合征冠状病毒2的抗原特异性适应性免疫和训练有素的免疫反应。 (你提供的原文似乎不完整,最后的“and.”不知具体内容,以上翻译是基于现有完整部分。)
Vaccines (Basel). 2022 May 4;10(5):721. doi: 10.3390/vaccines10050721.
4
Safety and immunogenicity of Nanocovax, a SARS-CoV-2 recombinant spike protein vaccine: Interim results of a double-blind, randomised controlled phase 1 and 2 trial.SARS-CoV-2重组刺突蛋白疫苗Nanocovax的安全性和免疫原性:1/2期双盲随机对照试验的中期结果
Lancet Reg Health West Pac. 2022 May 16;24:100474. doi: 10.1016/j.lanwpc.2022.100474. eCollection 2022 Jul.
5
Interim report: Safety and immunogenicity of an inactivated vaccine against SARS-CoV-2 in healthy chilean adults in a phase 3 clinical trial.中期报告:在智利健康成年人中进行的3期临床试验中,一种针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的灭活疫苗的安全性和免疫原性。
medRxiv. 2021 Apr 1:2021.03.31.21254494. doi: 10.1101/2021.03.31.21254494.
6
Why is WHO pushing back on a Health Canada-approved Medicago SARS-CoV-2 vaccine?为何世界卫生组织对加拿大卫生部批准的 Medicago 新冠疫苗持反对态度?
CMAJ. 2022 Apr 4;194(13):E504-E505. doi: 10.1503/cmaj.1095992.
7
Discovery of S-217622, a Noncovalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19.S-217622 的发现:一种非共价的口服 SARS-CoV-2 3CL 蛋白酶抑制剂临床候选药物,用于治疗 COVID-19。
J Med Chem. 2022 May 12;65(9):6499-6512. doi: 10.1021/acs.jmedchem.2c00117. Epub 2022 Mar 30.
8
BCG vaccination induces cross-protective immunity against pathogenic microorganisms.BCG 疫苗接种可诱导针对病原微生物的交叉保护免疫。
Trends Immunol. 2022 Apr;43(4):322-335. doi: 10.1016/j.it.2021.12.006. Epub 2022 Jan 22.
9
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine.由 SARS-CoV-2 灭活疫苗诱导的抗体和 T 细胞对关注变体的识别。
Front Immunol. 2021 Nov 9;12:747830. doi: 10.3389/fimmu.2021.747830. eCollection 2021.
10
Predictors associated with a better response to the Japanese aluminum-free hepatitis A vaccine, Aimmugen , for people living with HIV.与感染艾滋病毒者对日本无铝甲型肝炎疫苗Aimmugen反应更佳相关的预测因素。
Hepatol Res. 2022 Mar;52(3):227-234. doi: 10.1111/hepr.13736. Epub 2021 Dec 20.